Home › NDC Lookup › Ingredients › Guaifenesin And Dextromethorphan Hydrobr... › 63824-0056-36
Mucinex DM Guaifenesin and Dextromethorphan Hydrobromide 600 mg; 30 mg Tablet, Extended Release, 6-count — NDC 63824-0056-36 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Mucinex DM Guaifenesin and Dextromethorphan Hydrobromide 600 mg; 30 mg Tablet, Extended Release, 6-count — NDC 63824-056-36 (Billing 63824-0056-36)

by Reckitt Benckiser LLC · 1 BLISTER PACK in 1 CARTON / 6 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

This is a package of 6 tablets of Mucinex DM Guaifenesin and Dextromethorphan Hydrobromide 600 mg; 30 mg Tablet, Extended Release from Reckitt Benckiser LLC, marketed since Jun 2012 and currently FDA-listed; retail pharmacies pay about $0.6081 per tablet (NADAC).

NDC 63824-0056-36
🏷️ FDA NDC (as labeled) 63824-056-36 billing pads the product segment with a zero
This package
Contains6-count Cost per ea$0.6081 NADAC Per package$3.65 / 6 tablets Pack sizes10 compare ↓
Product page 63824-0056-01 Also comes in: 2 tablets 63824-056-72 2 tablets 63824-056-74 17 tablets 63824-056-89 20 tablets 63824-056-01 20 tablets 63824-056-32 20 tablets 63824-056-34 20 tablets 63824-056-69 20 tablets 63824-056-80 500 tablets 63824-056-50
OTC Brand On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Oct 1, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 63824-056-36 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
63824 labeler · 056 product · 36 package
Package marketed since
Jun 26, 2012
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Billing quantity
6 EA per package
Barcode (UPC)
0363824056203
FDA record last changed
Oct 1, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 63824-056-36
Product NDC 63824-056
11-digit billing NDC 63824005636
NCPDP billing unit EA — each (per item)
RxCUI 1298324
UNII 495W7451VQ, 9D2RTI9KYH
UPC 0363824056203
Application # NDA021620
SPL Set ID 70987d06-d206-445f-bd0d-5e1345b8465c
Established class (EPC) Expectorant
Physiologic effect Decreased Respiratory Secretion Viscosity; Increased Respiratory Secretions
DEA schedule Non-controlled
Marketing category NDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2012-06-26
Route ORAL
Dosage form TABLET, EXTENDED RELEASE
Substance GUAIFENESIN; DEXTROMETHORPHAN HYDROBROMIDE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 43997002527430
GPI class Mucinex DM
GCN Seq No 012074
GCN 53550
HICL code 000223
Ingredient (HICL) Guaifenesin/Dextromethorphan
HIC1 code B
Therapeutic class — broad (HIC1) Respiratory System
HIC2 code B3
Therapeutic class — intermediate (HIC2) Drugs Affecting Primarily The Trachea And Bronchi
HIC3 code B3T
Therapeutic class — specific (HIC3) Non-Opioid Antitussive And Expectorant Combination
AHFS code 48:08.00.00
AHFS class Antitussives
FDB label name MUCINEX DM ER 600-30 MG TABLET
FDB brand name Mucinex Dm
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 012074
  • GCN: 53550
  • GPI-14 (Medi-Span): 43997002527430
  • HICL (First Databank): 000223
  • AHFS class code: 48:08.00.00
  • RxCUI (RxNorm): 1298324
Why two NDCs? The FDA registers this code as 63824-056-36 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 63824-0056-36. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Uncompetitive N-methyl-D-aspartate Receptor Antagonist class.

Pharmacologic class Uncompetitive N-methyl-D-aspartate Receptor Antagonist, Sigma-1 Agonist
Drug family (ATC) Other antidepressants, Opium alkaloids and derivatives
How it works Uncompetitive NMDA Receptor Antagonists, Sigma-1 Receptor Agonists
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name MUCINEX DM ER 600-30 MG TABLET Ingredient Guaifenesin/Dextromethorphan
📗 Our plain-language guide HelloPharmacist
  • It helps loosen mucus and makes coughs more productive. It also temporarily eases cough from minor throat and bronchial irritation, like with a cold or inhaled irritants.
  • Swallow them whole with a full glass of water. Don’t crush, chew or break them. You can take them with or without food, about every 12 hours as your label directs.
  • How do I take the extended-release tablets?
  • The extended-release tablets are not for children under 12. Some liquid products are made for children, so check that product’s label and ask me if you’re unsure.
📖 Read our full Dextromethorphan / Guaifenesin guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.608 $3.65 / 6 tablets
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Dec 2023 $0.608 $0.608
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startMarketing endStatus
63824-0056-01 63824-056-01 Main listing 5 BLISTER PACK in 1 CARTON / 20 TABLET, EXTENDED RELEASE in 1 BLISTER PACK $0.6081 / ea $60.81 2012-06-26 — Discontinued by firm
63824-0056-32 63824-056-32 1 BLISTER PACK in 1 CARTON / 20 TABLET, EXTENDED RELEASE in 1 BLISTER PACK $0.6081 / ea $12.16 2012-06-26 — Active
63824-0056-34 63824-056-34 2 BLISTER PACK in 1 CARTON / 20 TABLET, EXTENDED RELEASE in 1 BLISTER PACK $0.6081 / ea $24.32 2012-06-26 — Active
63824-0056-36 You're viewing this 1 BLISTER PACK in 1 CARTON / 6 TABLET, EXTENDED RELEASE in 1 BLISTER PACK $0.6081 / ea $3.65 2012-06-26 — Active
63824-0056-50 63824-056-50 500 TABLET, EXTENDED RELEASE in 1 BOTTLE $0.6081 / ea $304.06 2021-06-01 — Discontinued by firm
63824-0056-69 63824-056-69 3 BLISTER PACK in 1 CARTON / 20 TABLET, EXTENDED RELEASE in 1 BLISTER PACK — — 2012-06-26 — Active
63824-0056-72 63824-056-72 2 TABLET, EXTENDED RELEASE in 1 POUCH — — 2012-06-26 — Active
63824-0056-74 63824-056-74 24 POUCH in 1 CARTON / 2 TABLET, EXTENDED RELEASE in 1 POUCH — — 2012-06-26 — Active
63824-0056-89 63824-056-89 4 BLISTER PACK in 1 CARTON / 17 TABLET, EXTENDED RELEASE in 1 BLISTER PACK $0.6081 / ea $41.35 2018-03-30 — Discontinued by firm
63824-0056-80 63824-056-80 2 BLISTER PACK in 1 CARTON / 20 TABLET, EXTENDED RELEASE in 1 BLISTER PACK — — 2024-05-01 — Active

This pack effectively ties for the lowest per-ea cost of the 6 priced pack sizes ($0.6081 NADAC).

Pack size FAQ

What quantity is in this package?
This is a 6-count package — 1 blister pack in 1 carton / 6 tablet, extended release in 1 blister pack.
How does this package differ from NDC 63824-0056-72?
Both are Mucinex DM Guaifenesin and Dextromethorphan Hydrobromide 600 mg; 30 mg Tablet, Extended Release — the drug itself is identical. This page's package is the 6-count one, while NDC 63824-0056-72 is the 2 tablets package.
What NDC number is used to bill for this package of Mucinex DM Guaifenesin and Dextromethorphan Hydrobromide 600 mg; 30 mg Tablet, Extended Release?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Mucus Relief DM Extended Release Caplets 600 mg/1; 30 mg 00536-1161-34 Rugby 20 tablets $0.356 — Availability likely save 41%
Rugby Mucus Relief DM ER 30 mg/1; 600 mg 00536-1446-34 Rugby 20 tablets $0.356 — Availability likely save 41%
Good Neighbor Pharmacy Mucus Dm 30 mg/1; 600 mg 46122-0817-61 Amerisource 20 tablets $0.356 — Availability likely save 41%
Leader Mucus Relief DM 30 mg/1; 600 mg 70000-0722-01 Cardinal 20 tablets $0.356 — Availability likely save 41%
Mucus Relief DM 600 mg/1; 30 mg 70677-1050-01 Strategic 1 tablet $0.356 — Availability likely save 41%
Mucus Relief DM 600 mg/1; 30 mg 70000-0491-01 CARDINAL 20 tablets $0.359 — Discontinued save 41%
Mucinex DM 600 mg/1; 30 mgthis 63824-0056-36 Reckitt 6 tablets $0.608 — FDA listed —
Good Sense Mucus DM 30 mg/1; 600 mg 00113-2219-01 L. 20 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 00363-0474-01 WALGREEN 10 tablets — — FDA listed —
Mucus Relief DM Extended Release Caplets 600 mg/1; 30 mg 00363-0733-20 Walgreens 20 tablets — — FDA listed —
Mucus Relief DM 30 mg/1; 600 mg 00363-3219-01 Walgreen 20 tablets — — FDA listed —
up and up mucus relief dm 30 mg/1; 600 mg 11673-0716-01 Target 20 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 11822-0733-02 Rite 20 tablets — — FDA listed —
mucus relief DM 30 mg/1; 600 mg 11822-2219-00 Rite 20 tablets — — FDA listed —
Mucus Relief DM Extended Release Caplets 600 mg/1; 30 mg 17856-1162-01 ATLANTIC 1 tablet — — FDA listed —
Mucus Relief Dm 600 mg/1; 30 mg 21130-0997-67 Better 10 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 600 mg/1; 30 mg 30142-0276-20 KROGER 10 tablets — — FDA listed —
Guaifenesin And Dextromethorphan Hbr 600 mg/1; 30 mg 30142-0948-20 Kroger 20 tablets — — FDA listed —
Topcare Mucus DM 30 mg/1; 600 mg 36800-0219-01 Topco 20 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 37808-0733-40 H 40 tablets — — FDA listed —
equaline mucus dm 30 mg/1; 600 mg 41163-0599-01 United 20 tablets — — FDA listed —
mucus relief dm 30 mg/1; 600 mg 41250-0436-01 Meijer 20 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 600 mg/1; 30 mg 41415-0998-20 PUBLIX 20 tablets — — FDA listed —
Mucus Dm 30 mg/1; 600 mg 42507-0222-20 HyVee 20 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBR 600 mg/1; 30 mg 43598-0114-01 Dr. 20 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBR 600 mg/1; 30 mg 43598-0231-01 Dr. 20 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 49035-0960-12 Wal-Mart 40 tablets — — FDA listed —
Mucinex Dm 600 mg/1; 30 mg 50090-1077-00 A-S 20 tablets — — FDA listed —
Mucinex DM 600 mg/1; 30 mg 50090-1078-00 A-S 20 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBR 600 mg/1; 30 mg 51316-0009-01 CVS 20 tablets — — FDA listed —
Cough And Congestion Extended Release 600 mg/1; 30 mg 51316-0065-67 CVS 10 tablets — — FDA listed —
Mucus Relief Dm 30 mg/1; 600 mg 51316-0858-78 CVS 100 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 600 mg/1; 30 mg 51660-0301-21 OHM 20 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 55910-0733-06 Dolgencorp, 6 tablets — — FDA listed —
DG health mucus dm 30 mg/1; 600 mg 55910-0746-01 Dolgencorp 20 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 600 mg/1; 30 mg 58602-0714-05 Aurohealth 14 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 600 mg/1; 30 mg 58602-0824-08 Aurohealth 10 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 600 mg/1; 30 mg 58602-0871-83 Aurohealth 10 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 59726-0733-06 P 6 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 60000-0058-67 Ahold 20 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 600 mg/1; 30 mg 63304-0106-21 SUN 20 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 63941-0733-20 Best 20 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 600 mg/1; 30 mg 65162-0038-03 Amneal 30 tablets — — FDA listed —
Mucinex DM, TRAVEL BASIX 600 mg/1; 30 mg 66715-6424-01 Lil' 2 tablets — — FDA listed —
Mucinex DM, CVP HEALTH 600 mg/1; 30 mg 66715-6524-01 Lil' 2 tablets — — FDA listed —
Mucinex DM 600 mg/1; 30 mg 66715-9724-01 Lil' 2 tablets — — FDA listed —
Mucus Relief DM Expectorant and Cough Suppressant 600 mg/1; 30 mg 67091-0314-20 Winco 10 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 67091-0344-20 WinCo 20 tablets — — FDA listed —
Mucinex DM 30 mg/1; 600 mg 67751-0171-01 Navajo 2 tablets — — FDA listed —
Mucus DM Extended Release 600 mg/1; 30 mg 69842-0057-11 CVS 10 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 69842-0933-20 CVS 20 tablets — — Discontinued —
mucus dm extended release 30 mg/1; 600 mg 69842-0963-01 CVS 20 tablets — — FDA listed —
Mucus Relief Dm 600 mg/1; 30 mg 72036-0012-20 Harris 10 tablets — — FDA listed —
basic care mucus dm 30 mg/1; 600 mg 72288-0219-49 Amazon.com 40 tablets — — FDA listed —
Amazon Basic Care Mucus Dm 600 mg/1; 30 mg 72288-0220-08 Amazon.com 10 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 72476-0733-20 Care 20 tablets — — FDA listed —
equate mucus relief dm 30 mg/1; 600 mg 79903-0065-01 WALMART 20 tablets — — FDA listed —
Mucinex DM 600 mg/1; 30 mg 85237-1650-01 Select 2 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 600 mg/1; 30 mg 85766-0150-14 Sportpharm 14 tablets — — FDA listed —
Good Sense Mucus DM 30 mg/1; 600 mg 85766-0172-20 Sportpharm 20 tablets — — FDA listed —
Mucinex DM 600 mg/1; 30 mg 85766-0176-20 Sportpharm 20 tablets — — FDA listed —
About this product: this is the brand-name version. Some generic versions are approved by the FDA, but we could not confirm current pharmacy availability from our pricing/market data.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2012
On the market since
Jun 2012
📍
2026
Currently FDA-listed
14 years listed
🔒
·
Generic approved (availability unconfirmed)
see note
🔒Generic approved by FDA, but pharmacy availability is not confirmed

The FDA lists approved generic versions of this medicine, but that does not always mean a pharmacy can get one today. Patent rules, launch agreements, supply and pricing can affect when generics actually arrive.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color white
ShapeOval
ImprintMucinex;600
Size16 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Dextromethorphan / Guaifenesin inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII LMI26O6933
    Alumina is a white powder form of aluminum oxide. It's used as a filler to add bulk to tablets and capsules, and sometimes as a thickening or anti-caking agent in powdered formulations.
  • UNII HHT01ZNK31
    Carbomer Homopolymer Type B is a synthetic polymer made from acrylic acid. It absorbs water and forms a gel, so it's used in medicines as a thickener, suspending agent, and to help create a smooth texture in creams, gels, and lotions.
  • UNII 35SW5USQ3G
    A synthetic yellow dye used to color medicines. It helps make tablets, capsules, and liquids visually distinct so patients can easily identify their medication.
  • UNII 3NXW29V3WO
    Hypromellose is a plant-based thickener made from cellulose. It's used in medicines as a binder to hold ingredients together, a coating for tablets, and a thickener for liquids.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.

6 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statescarbomer homopolymer type B; D&C yellow no. 10 aluminum lake; hypromellose, USP; magnesium stearate, NF; microcrystalline cellulose, NF; sodium starch glycolate, NF

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerReckitt Benckiser LLC
Application holderRECKITT BENCKISER LLC
FDA applicationNDA021620 (NDA)
Labeler code63824
First marketedJun 2012
Product typeHuman Otc Drug
Portfolio174 products on file

More NDCs from Reckitt Benckiser LLC labeler code 63824

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 56 words ▾

Uses helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive temporarily relieves: cough due to minor throat and bronchial irritation as may occur with the common cold or inhaled irritants the intensity of coughing the impulse to cough to help you get to sleep

⏱️ Dosage and Administration 60 words ▾

Directions do not crush, chew, or break extended-release tablet take with a full glass of water this product can be administered without regard for timing of meals adults and children 12 years and older: 1 or 2 extended-release tablets every 12 hours; not more than 4 extended-release tablets in 24 hours children under 12 years of age: do not use

⚠️ Warnings 164 words ▾

Warnings Do not use for children under 12 years of age if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product. Ask a doctor before use if you have persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema cough accompanied by too much phlegm (mucus) When using this product do not use more than directed Stop use and ask a doctor if cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache.

These could be signs of a serious illness. If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

📦 Storage and Handling 6 words ▾

Other information store at 20-25°C (68-77°F)

🧪 Active Ingredient 30 words ▾

Active ingredients (in each extended-release tablet) Dextromethorphan HBr 30 mg Guaifenesin 600 mg Active ingredients (in each extended-release tablet) Purposes Dextromethorphan HBr 30 mg Cough suppressant Guaifenesin 600 mg Expectorant

🧪 Inactive Ingredients 24 words ▾

Inactive ingredients carbomer homopolymer type B; D&C yellow no. 10 aluminum lake; hypromellose, USP; magnesium stearate, NF; microcrystalline cellulose, NF; sodium starch glycolate, NF

🎯 Purpose 17 words ▾

Active ingredients (in each extended-release tablet) Purposes Dextromethorphan HBr 30 mg Cough suppressant Guaifenesin 600 mg Expectorant

📄 Do Not Use 62 words ▾

Do not use for children under 12 years of age if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

📄 Ask a Doctor Before Use If 29 words ▾

Ask a doctor before use if you have persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema cough accompanied by too much phlegm (mucus)

📄 When Using This Product 10 words ▾

When using this product do not use more than directed

📄 Stop Use and Ask a Doctor If 31 words ▾

Stop use and ask a doctor if cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness.

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 21 words ▾

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

📄 Questions or Comments 3 words ▾

Questions? 1-866-MUCINEX (1-866-682-4639)

📄 Package Label / Principal Display Panel 45 words ▾

PRINCIPAL DISPLAY PANEL - 20 Tablet Blister Pack Carton NDC 63824-056-32 Mucinex®DM 600 mg guaifenesin & 30 mg dextromethorphan HBr extended-release tablets EXPECTORANT & COUGH SUPPRESSANT 12 HOUR ® Controls Cough Thins and Loosens Mucus Immediate and Extended Release 20 EXTENDED-RELEASE TABLETS full carton label

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Mucinex DM (this brand).

Top reported reactions

Dizziness366
Diarrhoea345
Nausea287
Dyspnoea211
Fatigue192
Headache187
Vomiting171

Age at onset

Child2
Adolescent1
Adult127
Elderly149

Reporter sex

3,948 reports
Male · 34%
Female · 66%
Unknown · 0%

Serious outcomes

Hospitalization535
Death89
Life-threatening36
Disabling27
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 356 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
← 63824-0041-12 · Reckitt 63824-0057-18 · Reckitt →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.